PHNO refers to phenoxybenzamine, a non-selective alpha-adrenergic antagonist belonging to the phenoxylamine class of drugs. This pharmaceutical agent is primarily utilized to manage hypertension and benign… Read more
PHNO refers to phenoxybenzamine, a non-selective alpha-adrenergic antagonist belonging to the phenoxylamine class of drugs. This pharmaceutical agent is primarily utilized to manage hypertension and benign prostatic hyperplasia by blocking alpha-1 adrenergic receptors, which facilitates the relaxation of smooth muscle in both the prostate and blood vessels. In pharmaceutical development and manufacturing, high-quality reference standards are essential for accurate analytical testing and rigorous quality control. This category provides the necessary materials, including the parent compound and its stable isotope labelled analogues, such as PHNO-d7, which are critical for conducting reliable impurity profiling and quantitative analysis. By utilizing these precise chemical standards, laboratories can ensure the integrity of method validation processes and maintain compliance with stringent regulatory requirements throughout the drug development lifecycle.